<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000046126">
  <TermName>nolatrexed</TermName>
  <TermPronunciation>(NOH-luh-TREK-sed)</TermPronunciation>
  <TermDefinition>
    <DefinitionText>A substance that is being studied in the treatment of liver cancer. It belongs to the family of drugs called thymidylate synthase inhibitors. Also called AG337 and Thymitaq.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000731399" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;nolatrexed&quot;" language="en" id="_3"/>
  <MediaLink ref="CDR0000731398" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;nolatrexed&quot;" language="es" id="_4"/>
  <SpanishTermName>nolatrexed</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Sustancia en estudio para el tratamiento del cáncer de hígado. Es un tipo de inhibidor de la timidilato de sintasa. También se llama AG337 y Thymitaq.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateLastModified>2005-05-19</DateLastModified>
</GlossaryTerm>
